Literature DB >> 8143615

Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations.

H Vainio1, K Husgafvel-Pursiainen, S Anttila, A Karjalainen, P Hackman, T Partanen.   

Abstract

To investigate the role of tobacco smoking and asbestos fibers in the etiology of human lung cancer, we examined the activating point mutations in the K-ras oncogene in DNA samples from 49 patients. Mutations were found more often in tissue from adenocarcinomas (12/21) than in tissue from tumors other than nonadenocarcinomas of the lung (3/28). Among the adenocarcinoma patients, asbestos exposure was predictive of K-ras mutation (odds ratio, 4.9; 95% confidence interval, 0.7-34.3); in patients with other types of lung cancer, the relation appeared to be an inverse one, but the numbers were small. The proportion of heavy smokers (over 50 pack-years) was 60% among people with K-ras mutations and 35% among the K-ras-negative subjects, suggesting that smoking causes K-ras mutations. If mutations in K-ras genes are caused by smoking, asbestos would act as a promoting agent by conferring selective growth conditions for clonal expansion on these mutated cells. Asbestos may favor recruitment of (initiated) K-ras mutation-positive cells in the multistage process of carcinogenesis by stimulating cellular growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143615      PMCID: PMC1521170          DOI: 10.1289/ehp.93101s3189

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Serum oncoproteins and growth factors in asbestosis and silicosis patients.

Authors:  P W Brandt-Rauf; S Smith; K Hemminki; H Koskinen; H Vainio; H Niman; J Ford
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

2.  Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

Authors:  R J Slebos; R H Hruban; O Dalesio; W J Mooi; G J Offerhaus; S Rodenhuis
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

3.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

Authors:  R J Slebos; R E Kibbelaar; O Dalesio; A Kooistra; J Stam; C J Meijer; S S Wagenaar; R G Vanderschueren; N van Zandwijk; W J Mooi
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

4.  A study of the histological cell types of lung cancer in workers suffering from asbestosis in the United Kingdom.

Authors:  F Whitwell; M L Newhouse; D R Bennett
Journal:  Br J Ind Med       Date:  1974-10

Review 5.  The interactions of tobacco smoking and other agents in cancer etiology.

Authors:  R Saracci
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

6.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Authors:  S Rodenhuis; R J Slebos; A J Boot; S G Evers; W J Mooi; S S Wagenaar; P C van Bodegom; J L Bos
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

Review 7.  The ras oncogenes in human lung cancer.

Authors:  S Rodenhuis; R J Slebos
Journal:  Am Rev Respir Dis       Date:  1990-12

Review 8.  Interaction between tobacco smoking and occupational exposures in the causation of lung cancer.

Authors:  K Steenland; M Thun
Journal:  J Occup Med       Date:  1986-02

9.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.

Authors:  M You; U Candrian; R R Maronpot; G D Stoner; M W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.

Authors:  K Husgafvel-Pursiainen; M Ridanpää; P Hackman; S Anttila; A Karjalainen; A Onfelt; A L Børresen; H Vainio
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.